Diabetes
News
Newly approved tirzepatide’s retail price announced
The recently approved twincretin will carry a U.S. retail price similar to one of its main competitors, semaglutide, but patient discounts will be...
Commentary
Does COVID-19 raise the risk for diabetes?
Some data say yes and other data say no. Dr. Anne L. Peters sorts it out.
Conference Coverage
Pancreatic involvement in COVID-19: What do we know?
“Our data identify the human pancreas as a target of SARS-CoV-2 infection and suggest that pancreatic beta cell involvement could contribute to...
News
Could new therapy for food ‘cues’ improve weight loss?
Patients highly sensitive to food ‘cues’ may benefit from behavioral therapy, but the intervention is labor intensive and tied to modest weight...
News
Grit your teeth for a lesser-known complication of diabetes
Tooth loss is a lesser-known potential complication of type 2 diabetes. A large meta-analysis quantifies the risk.
News
Screening for diabetes at normal BMIs could cut racial disparities
Diabetes screening for Asian and Black individuals aged 35 and over, even at BMIs that are not considered overweight, would be ‘a good place to...
Conference Coverage
Vegan diet helps shed pounds but doesn’t dint diabetes
A vegan diet most likely led to weight loss because it is “associated with a reduced calorie intake due to a lower content of fat and higher...
Conference Coverage
Calorie counting and exercise ‘of limited value’ for obesity weight loss
“Our survey results indicate that, while the majority of adults with obesity are actively trying to reduce their weight, using a variety of...
News
Topline results for dapagliflozin in HFpEF: DELIVER
AstraZeneca says regulatory submissions will be forthcoming, potentially bringing a second SGLT2 inhibitor in this space, after empagliflozin.
Conference Coverage
New research holds promise for fighting obesity, says expert
A growing understanding of adipose tissue as an endocrine organ responsible for weight control opens avenues for treatment, she says.